ArticleFrontiers in pharmacology2023

Identification of afatinib-associated ADH1B and potential small-molecule drugs targeting ADH1B for hepatocellular carcinoma.

Yongxu Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.